492 related articles for article (PubMed ID: 29991873)
1. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends.
Mijan MA; Lim BO
World J Gastroenterol; 2018 Jul; 24(25):2673-2685. PubMed ID: 29991873
[TBL] [Abstract][Full Text] [Related]
2. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
3. Nutritional Interventions Using Functional Foods and Nutraceuticals to Improve Inflammatory Bowel Disease.
Shin DW; Lim BO
J Med Food; 2020 Nov; 23(11):1136-1145. PubMed ID: 33047999
[TBL] [Abstract][Full Text] [Related]
4. Potential role of nutraceutical compounds in inflammatory bowel disease.
Larussa T; Imeneo M; Luzza F
World J Gastroenterol; 2017 Apr; 23(14):2483-2492. PubMed ID: 28465632
[TBL] [Abstract][Full Text] [Related]
5. Review of natural products actions on cytokines in inflammatory bowel disease.
Hur SJ; Kang SH; Jung HS; Kim SC; Jeon HS; Kim IH; Lee JD
Nutr Res; 2012 Nov; 32(11):801-16. PubMed ID: 23176791
[TBL] [Abstract][Full Text] [Related]
6. Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways.
Huang Y; Zhang Y; Wan T; Mei Y; Wang Z; Xue J; Luo Y; Li M; Fang S; Pan H; Wang Q; Fang J
Cell Biol Toxicol; 2021 Feb; 37(1):113-128. PubMed ID: 33130971
[TBL] [Abstract][Full Text] [Related]
7. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease.
Debnath T; Kim DH; Lim BO
Molecules; 2013 Jun; 18(6):7253-70. PubMed ID: 23783459
[TBL] [Abstract][Full Text] [Related]
8. Curcumin has bright prospects for the treatment of inflammatory bowel disease.
Hanai H; Sugimoto K
Curr Pharm Des; 2009; 15(18):2087-94. PubMed ID: 19519446
[TBL] [Abstract][Full Text] [Related]
9. Diet and inflammatory bowel disease: review of patient-targeted recommendations.
Hou JK; Lee D; Lewis J
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1592-600. PubMed ID: 24107394
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory pathways of importance for management of inflammatory bowel disease.
Pedersen J; Coskun M; Soendergaard C; Salem M; Nielsen OH
World J Gastroenterol; 2014 Jan; 20(1):64-77. PubMed ID: 24415859
[TBL] [Abstract][Full Text] [Related]
11. Role of Inflammation in the Development of Colorectal Cancer.
Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
[TBL] [Abstract][Full Text] [Related]
12. γ-Glutamyl cysteine and γ-glutamyl valine inhibit TNF-α signaling in intestinal epithelial cells and reduce inflammation in a mouse model of colitis via allosteric activation of the calcium-sensing receptor.
Zhang H; Kovacs-Nolan J; Kodera T; Eto Y; Mine Y
Biochim Biophys Acta; 2015 May; 1852(5):792-804. PubMed ID: 25558818
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of combination of platelet lysate and sulfasalazine administration in TNBS-induced colitis in rat.
Yousefi-Ahmadipour A; Ebrahimi-Barough S; Niknia S; Allahverdi A; Mirzahosseini-Pourranjbar A; Tashakori M; Khajouee Ravari S; Asadi F; Heidari Barchi Nezhad R; Lotfibakhshaiesh N; Mirzaei MR
Biomed Pharmacother; 2020 May; 125():109949. PubMed ID: 32058216
[TBL] [Abstract][Full Text] [Related]
14. Research progress in the treatment of inflammatory bowel disease with natural polysaccharides and related structure-activity relationships.
Chen J; Gao Y; Zhang Y; Wang M
Food Funct; 2024 Jun; 15(11):5680-5702. PubMed ID: 38738935
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in biological therapy for inflammatory bowel disease.
Kurtovic J; Segal I
Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
[TBL] [Abstract][Full Text] [Related]
16. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
17. Study of tumor necrosis factor receptor in the inflammatory bowel disease.
Souza RF; Caetano MAF; Magalhães HIR; Castelucci P
World J Gastroenterol; 2023 May; 29(18):2733-2746. PubMed ID: 37274062
[TBL] [Abstract][Full Text] [Related]
18. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
Lewis JD; Abreu MT
Gastroenterology; 2017 Feb; 152(2):398-414.e6. PubMed ID: 27793606
[TBL] [Abstract][Full Text] [Related]
19. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease.
Uranga JA; López-Miranda V; Lombó F; Abalo R
Pharmacol Rep; 2016 Aug; 68(4):816-26. PubMed ID: 27267792
[TBL] [Abstract][Full Text] [Related]
20. Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice.
Song WJ; Li Q; Ryu MO; Nam A; An JH; Jung YC; Ahn JO; Youn HY
Res Vet Sci; 2019 Aug; 125():176-184. PubMed ID: 31247473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
